Search Results for "Lipitor"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Lipitor. Results 1 to 4 of 4 total matches.
See also: atorvastatin
Evinacumab (Evkeeza) for Homozygous Familial Hypercholesterolemia
The Medical Letter on Drugs and Therapeutics • May 03, 2021 (Issue 1623)
Lipitor (Pfizer) 493.50
Rosuvastatin – generic 20-40 mg PO once/day 6.30
Crestor (AstraZeneca) 276.60 ...
The FDA has approved evinacumab-dgnb (Evkeeza –
Regeneron), an angiopoietin-like 3 (ANGPTL3) inhibitor,
for adjunctive IV treatment of homozygous familial
hypercholesterolemia (HoFH) in patients ≥12 years
old. Evinacumab is the first ANGPTL3 inhibitor to be
approved in the US.
Comparison Table: Some Lipid-Lowering Drugs (online only)
The Medical Letter on Drugs and Therapeutics • Sep 19, 2022 (Issue 1659)
Atorvastatin – generic
Lipitor (Pfizer)
10, 20, 40, 80 mg tabs Initial: 10-20 mg PO once/day
Maximum: 80 mg ...
View the Comparison Table: Some Lipid-Lowering Drugs
Drugs for Chronic Heart Failure
The Medical Letter on Drugs and Therapeutics • Jun 14, 2021 (Issue 1626)
(OATP) 1B1; concomitant use of
drugs that inhibit OATP1B1, such as atorvastatin
(Lipitor, and others ...
Among patients with chronic heart failure, those with
a left ventricular ejection fraction (LVEF) ≤40% are
considered to have heart failure with reduced ejection
fraction (HFrEF). Patients with a LVEF ≥50% are
considered to have heart failure with preserved ejection
fraction (HFpEF). Those with a LVEF of 41-49% are an
intermediate group more similar to patients with HFpEF.
Lipid-Lowering Drugs
The Medical Letter on Drugs and Therapeutics • Sep 19, 2022 (Issue 1659)
– generic 10, 20, 40, 80 mg tabs Initial: 10-20 mg PO once/day 35-40% $5.10
Lipitor (Pfizer) Maximum: 80 mg ...
Cholesterol management guidelines from the
American College of Cardiology/American Heart
Association Task Force were last published in 2019.